The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: Implications for neuronal and tumor cell survival

Genes and Development

Volumn 13, Issue 16, 1999, Pages 2087-2097

  Okano, Hirotaka J ^a   Park, Woong Y ^a,b   Corradi, John P ^a,c   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c JACKSON LABORATORY   (United States)

Author keywords

c Myc function; Cerebellar degeneration; Leucine zipper protein; Paraneoplastic neurological disease; Purkinje neurons

Indexed keywords

ANTIGEN CDR2; CYTOPLASM PROTEIN; LEUCINE ZIPPER PROTEIN; MYC PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL SURVIVAL; CEREBELLUM DEGENERATION; CONTROLLED STUDY; FEMALE GENITAL TRACT TUMOR; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NERVE CELL NECROSIS; NONHUMAN; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; RAT; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR IMMUNITY;

ANIMALIA;

EID: 0033567137     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.16.2087     Document Type: Article

References (61)

1. Albert, M.L., J.C. Darnell, A. Bender, L.M. Francisco, N. Bhardwaj, and R.B. Darnell. 1998. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Med. 4: 1321-1324.
2. Ayer, D.E., L. Kretzner, and R.N. Eisenman. 1993. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211-222.
3. Bai, M.K., J.S. Costopoulos, B.P. Christoforidou, and C.S. Papadimitriou. 1994. Immunohistochemical detection of the c-myc oncogene product in normal, hyperplastic and carcinomatous endometrium. Oncology 51:314-319.
4. Bao, J. and A.S. Zervos. 1996. Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene 12: 2171-2176.
5. Blackwood, E.M., B. Luscher, and R.N. Eisenman. 1992. Myc and Max associate in vivo. Genes & Dev 6: 71-80.
6. Boni, R., O. Bantschapp, B. Muller, and G. Burg. 1998. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma. Dermatology 196: 288-291.
7. Borges, L.F., P.J. Elliott, R. Gill, S.D. Iversen, and L.L. Iversen. 1985. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science 228: 346-348.
8. Corradi, J.P., C.W. Yang, J.C. Darnell, J. Dalmau, and R.B. Darnell. 1997. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J. Neurosci. 17: 1406-1415,
9. Corriveau, R.A., G.S. Huh, and C.J. Shatz. 1998. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21: 505-520.
10. Craig, R.W., H.L. Buchan, C.I. Civin, and M.B. Kastan. 1993. Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-l human myeloid leukemia cells. Cell Growth Diff. 4:349-357.
11. DiDonato, J.A., M. Hayakawa, D.M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554.
12. Dropcho, E., Y. Chen, J. Posner, and L. Old. 1987. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. 84: 1-5.
13. Evan, G. and T. Littlewood. 1998. A matter of life and cell death. Science 281: 1317-1321.
14. Fabian, R.H. and G. Petroff. 1987. Intraneuronal IgG in the central nervous system: Uptake by retrograde axonal transport. Neurology 37:1780-1784.
15. Fathallah-Shaykh, H., S. Wolf, E. Wong, J. Posner, and H. Furneaux. 1991. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. 88: 3451-3454.
16. Feddersen, R.M., R. Ehlenfeldt, W.S. Yunis, H.B. Clark, and H.T. Orr. 1992. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron 9: 955-966.
17. Feddersen, R.M., H.B. Clark, W.S. Yunis, and H.T. Orr. 1995. In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Mol. Cell. Neurosci. 6: 153-167.
18. Flaris, N.A., T.L. Densmore, M.C. Molleston, and W.F. Hickey. 1993. Characterization of microglia and macrophages in the central nervous system of rats: Definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 7: 34-40.
19. Furneaux, H.F., L. Reich, and J.B. Posner. 1990. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085-1091.
20. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
21. Graus, F., I. Illa, M. Agusti, T. Ribalta, F. Cruz-Sanchez, and C. Juarez 1991. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J. Neurol. Sci. 106: 82-87.
22. Green, D.R. 1997. A Myc-induced apoptosis pathway surfaces. Science 278: 1246-1247.
23. Groyer, A., G. Schweizer-Groyer, F. Cadepond, M. Mariller, and E.E. Baulieu. 1987. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro. Nature 328: 624-626.
24. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
25. Heintz, N. 1993. Cell death and the cell cycle: A relationship between transformation and neurodegeneration? Trends Biochem. Sci. 18: 157-159.
26. Hida, C., T. Tsukamoto, H. Awano, and T. Yamamoto. 1994. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration. Arch. Neurol. 51: 555-558.
27. Hurlin, P.J., C. Queva, P.J. Koskinen, E. Steingrimsson, D.E. Ayer, N.G. Copeland, N.A. Jenkins, and R.N. Eisenman. 1996. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 15: 2030.
28. Hurlin, P.J. C. Queva, and R.N. Eisenman. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes & Dev. 11: 44-58.
29. Ito, M. 1990. A new physiological concept on cerebellum. Rev. Neurol. 146: 564-569.
30. Kretzner, L., E.M. Blackwood, and R.N. Eisenman. 1992. Myc and max proteins possess distinct transcriptional activities. Nature 359: 426-429.
31. Lebrun, S.J., R.L. Shpall, and L. Naumovski. 1998. Interferon-induced upregulation and cytoplasmic localization of Myc-interacting protein Nmi. J. Interferon Cytokine Res. 18: 767-771.
32. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone, 1996. CD28/ B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
33. Lipponen, P.K. 1995, Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. J. Pathol. 175: 203-210.
34. McCormack, M.A., K.M. Rosen, L, Villa-Komaroff, and G.D. Mower. 1992. Changes in immediate early gene expression during postnatal development of cat cortex and cerebellum. Brain Res. Mol. Brain Res. 12: 215-223.
35. McMahon, S.B., H.A. Van Buskirk, K.A. Dugan, T.D. Copeland, and M.D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F onco-proteins. Cell 94: 363-374.
36. Miyazawa, A., M. Takahashi, T. Horikoshi, and T. Yoshioka. 1993. Immunohistochemical analysis of signal transduction system in developing rat Purkinje cell by using antibodies for signaling molecules. Ann. N. Y. Acad. Sci. 707: 533-535.
37. Morgan, J.I. and T. Curran. 1995. Immediate-early genes: Ten years on. Trends Neurosci. 18: 66-67.
38. Morgan, J.I., D.R. Cohen, J.L. Hempstead, an T. Curran. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237: 192-197.
39. Peterson, K., M.K. Rosenblum, H. Kotanides, and J.B. Posner. 1992. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42: 1931-1937.
40. Peukert, K., P. Staller, A. Schneider, G. Carmichael, F. Hanel, and M. Eilers. 1997. An alternative pathway for gene regulation by Myc. EMBO J. 16: 5672-5686.
41. Pietilainen, T., P. Lipponen, S. Aaltomaa, M. Eskelinen, V.M. Kosma, and K. Syrjanen. 1995. Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res. 15: 959-964.
42. Posner, J.B. 1995. Neurologic complications of cancer. F.A. Davis, Philadelphia, PA.
43. Prives, C. 1998. Signaling to p53: Breaking the MDM2-p53 circuit. Cell 95: 5-8.
44. Rao, A., C. Luo, and P.G. Hogan. 1997. Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 15: 707-747.
45. Royds, J.A., R.M. Sharrard, B. Wagner, and S.V. Polacarz. 1992. Cellular localisation of c-myc product in human colorectal epithelial neoplasia. J. Pathol. 166: 225-233.
46. Ruppert, C., D. Goldowitz, and W. Wille. 1986. Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages. EMBO J. 5: 1897-1901.
47. Sakai, K., D.J. Mitchell, T. Tsukamoto, and L. Steinman. 1990. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 28: 692-698.
48. Sakai, K., T. Ogasawara, G. Hirose, K.A. Jaeckle, and J.E. Greenlee. 1993. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. Ann. Neurol. 33: 373-380.
49. Sakamuro, D., K.J. Elliott, R. Wechsler-Reya, and G.C. Prendergast. 1996. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nature Genet. 14: 69-77.
50. Sasano, H., H. Nagura, and S.G. Silverberg. 1992. Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary. Hum. Pathol. 23: 491-495.
51. Schmilz, M.L. and P.A. Baeuerle. 1995. Multi-step activation of NF-kappa B/Rel transcription factors. Immunobiology 193: 116-127.
52. Shrivastava, A., S. Saleque, G.V. Kalpana, S. Artandi, S.P. Goff, and K. Calame. 1993, Inhibition of transcriptional regulator Yin-Yang-l by association with c-Myc. Science 262: 1889-1892.
53. Takahashi, M., S. Toyoshima, A. Miyazawa, T. Horikoshi, and T. Yoshioka. 1993. Regulation of c-MYC protein expression in the developing rat cerebellum by phosphoinositide turn-over. Biochem. Biophys. Res. Commun. 197: 278-286.
54. Takanaga, H., H. Mukai, H. Shibata, M. Toshimori, and Y. Ono. 1998. PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. Exp. Cell Res. 241: 363-372.
55. Ulrich, E., A. Duwel, A. Kauffmann-Zeh, C. Gilbert, D. Lyon, B. Rudkin, G. Evan, and D. Martin-Zanca. 1998. Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene 16: 825-832.
56. van Steensel, B. and T. de Lange. 1997. Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743.
57. Verschuuren, J., L. Chuang, M.K. Rosenblum, F. Lieberman, A. Pryor, J.B. Posner, and J. Dalmau. 1996. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 91: 519-525.
58. Vriz, S., J.M. Lemaitre, M. Leibovici, N. Thierry, and M. Mechali. 1992. Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression. Mol. Cell. Biol. 12: 3548-3555.
59. Wakamatsu, Y., Y. Watanabe, A. Shimono, and H. Kondoh. 1993. Transition of localization of the N-Myc protein from nucleus to cytoplasm in differentiating neurons. Neuron 10: 1-9.
60. Wang, Y., R. Toury, M. Hauchecorne, and N. Balmain. 1997. Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats. Cell. Mol. Biol. 43: 175-188.
61. Zindy, F., C.M. Eischen, D.H. Randle, T. Kamijo, J.L. Cleveland, C.J. Sherr, and M.F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Dev. 12: 2424-2433.